Download Preventive therapy for TB exposure

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Childhood immunizations in the United States wikipedia , lookup

Globalization and disease wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Traveler's diarrhea wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Eradication of infectious diseases wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Infection wikipedia , lookup

Transmission (medicine) wikipedia , lookup

Infection control wikipedia , lookup

Transcript
Preventive therapy for TB exposure/infection
Screen all children in close contact with an infectious pulmonary TB case for TB disease. Screening includes
clinical history/examination and, if available, chest X-ray and tuberculin skin test (TST). Give antituberculosis
treatment if the diagnosis of TB disease is confirmed or suspected.
Indications for TB Preventive Therapy:
» All asymptomatic children < 5 years of age, or HIV-infected irrespective of age, i.e. clinically normal, normal
chest X-ray and TST positive or negative, in close contact with an infectious pulmonary TB case should
receive isoniazid preventive therapy (IPT).
» Children < 5 years of age, or HIV-infected irrespective of age, who have had no previous TB treatment or
preventive therapy, are asymptomatic without a history of close contact with an infectious pulmonary TB
case but found to have a positive TST.
» Previous isoniazid preventive therapy or treatment does not protect the child against subsequent TB
exposure/infection. If there is re-exposure to an infectious pulmonary TB case after completion of 6 months
of chemotherapy, children (< 5 years or HIV-infected) should receive IPT after each episode of documented
TB exposure for 6 months. In cases of re-exposure to infectious source cases while the child is on IPT, the
duration of IPT should continue for as long as the source case remains infectious.
Preventive therapy in case of drug-susceptible TB contact:

Isoniazid, oral, 10 mg/kg daily for 6 months.
Preventive therapy in case of drug-resistant TB contact:
Isoniazid monoresistance:

Rifampicin, oral, 15 mg/kg daily for 4 months.
Rifampicin monoresistance:

Isoniazid, oral, 10 mg/kg daily for 6 months.
MDR-TB:

Isoniazid, oral, 15-20mg/kg daily for 6 months

Ethambutol, oral, 20-25mg/kg daily for 6 months

Levofloxacin 15-20mg/kg daily for 6 months
Refer case if simplification of prophylaxis regimen is required
XDR-TB:

Close follow-up for two years.

Ensure household infection control practices are observed.

Refer all cases.